51.   That means emphasizing preventive care, which Medicaid patients frequently do without.

52.   The distinction, she said, was that non-terminal patients have a choice of whether to live or die, while terminally ill patients do not.

53.   The goal was to enable patients to eventually do without the powerful drugs that can keep the virus in check.

54.   The official clinical rationale was that patients do better in community settings.

55.   The placebo patients did worse on all measures Bosentan acts against a hormone called endothelin, which causes blood vessels to constrict, Channick says.

56.   The patient is doing fine.

57.   The patient must do it.

58.   The single case of cutaneous anthrax to have been identified here at that point had been treated for two weeks and the patient was doing well.

59.   They found little difference in how patients did, measured either by the need for follow-up treatment or by ratings given by those taking care of them.

60.   What should patients do in the meantime?